Atlas Trials

A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Clinical trial NCT02805179 · COMPLETED

Trial details

NCT number
NCT02805179
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioma
Start date
2016-09-22
Primary completion
2020-02-06
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.